Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.66 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.47 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | EPHX1 | P07099 | 9/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.44 |
| ▸ | FAAH | O00519 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27980206 | 0.82 | EPHX1 (0.49) | GPR84FFAR1EPHX1EPHX2 | |
| SCHEMBL23723115 | 0.81 | EPHX1 (0.52) | GPR84ALDH1A1KMT2AEPHX1EPHX2 | |
| SCHEMBL27046896 | 0.81 | EPHX1 (0.52) | GPR84ALDH1A1KMT2AEPHX1EPHX2 | |
| SCHEMBL4916940 | 0.81 | GPR84 (1.00) | GPR84FFAR4FFAR1FAAH | |
| SCHEMBL155391 | 0.81 | GPR84 (1.00) | GPR84FFAR4FFAR1FAAH | |
| SCHEMBL310070 | 0.81 | GPR84 (1.00) | GPR84FFAR4FFAR1FAAH | |
| SCHEMBL7077603 | 0.81 | GPR84 (1.00) | GPR84FFAR4FFAR1FAAH | |
| SCHEMBL311718 | 0.81 | GPR84 (1.00) | GPR84FFAR4FFAR1FAAH | |
| SCHEMBL7080958 | 0.81 | GPR84 (1.00) | GPR84FFAR4FFAR1FAAH | |
| SCHEMBL23698920 | 0.81 | GPR84 (1.00) | GPR84FFAR4FFAR1FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1409720-A | Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors | CORIXA CORP (US) | 2003-04-09 | — | — | CN | disclosed |